Cambridge Healthtech Institute’s 9th Annual
Preclinical Strategies, Models & Tools in Oncology
Translational Strategies, Novel Therapeutics and Tumor Models
June 2-4, 2020
The rise of cancer immunotherapy instigated unique preclinical and translational challenges. In addition to immuno-oncology advances, we are witnessing a new wave of targeted and novel therapies that enrich the arsenal of combination cancer therapies.
The demand for predictive and robust preclinical models and approaches to minimize translational failures in oncology and immuno-oncology is at an all-time high. The need for leveraging phenotypic features of models, for early identification of predictive
biomarkers, for rational design of combination therapies, and for researching the cancer-immune cell interactions add to the complexity of translational research in immuno-oncology. Cambridge Healthtech Institute’s 9th Annual Preclinical
Strategies, Models & Tools in Oncology conference is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Coverage will include, but is not limited to:
- Reverse translational studies to guide Cancer combination strategies
- Translational immuno-oncology
- Leveraging the best of industry and academia to create new cancer medicines
- Leveraging artificial intelligence in preclinical oncology
Novel Therapeutics and Combinations
- Targeting tumor microenvironment and resistance
- PARP inhibitors update
- Rational immunotherapy combination with non-IO agents
- New targets and approaches in oncology
- Application of humanized and syngeneic models: case studies
- Preclinical and translational imaging
- Integrating in vivo and in vitro modeling
- Human tumor organoids
If you would like to submit a proposal to give a presentation at this meeting, please click here.
The deadline for priority consideration is November 22, 2019.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For more details on the conference, please contact:
Marina Filshtinsnky, MD
Executive Director, Conferences
Cambridge Healthtech Institute
For partnering and sponsorship information, please contact:
Manager, Business Development
Joseph Vacca, M.S.
Director, Business Development